Orshe

Also: Price hike for last-resort insurance in California; potential warfarin replacements line up; dialysis deal reached in Atlanta; U.S. asks judge to allow embryonic stem cell research to proceed.

The rest is here:  A.M. Vitals: Genzyme Says Sanofi Needs to Cough Up More Cash

Mutations in the BRCA1 and BRCA2 genes raise the lifetime risk of breast cancer to as much as 84% and of ovarian cancer to as much as 63%.

Excerpt from:  Study Suggests Importance of Screening For BRCA Gene Mutations

At the Minnesota State Fair, families can sign up to give DNA samples for a research study.

Go here to read the rest: What Should You Ask Before You Give Up DNA? (At a State Fair or Elsewhere)

Brigham and Women’s Hospital is now screening patients for its hand-transplant program, one of only five in the country.

Read the original here:  Health Blog Q&A: Talking Hand Transplants With a Surgeon

A research center is devoted to XMRV, but its president says terminology may change as we learn more about the family of viruses being studied.

Read more: Betting on X — As in XMRV — With a Big-Ticket Research Center

The paper just published in PNAS didn’t find XMRV in the blood of CFS patients, but other viruses in the same family.

Go here to read the rest:  Does X (the Virus, That Is) Mark the Spot in Chronic Fatigue Syndrome?

Here’s why a much-awaited study on chronic fatigue syndrome and its possible association with a family of viruses was held until now.

View original post here:  PNAS Paper on Virus-Chronic Fatigue Syndrome Link Has Its Own Story

Older physicians may think younger ones don’t care; younger docs may think older ones put work above all else.

See the rest here:  Is There a Generational Clash in the Medical Workplace?

The authors of a new paper write that if traumatic brain injury were considered a chronic disease it could be managed as such.

View original here:  Should Traumatic Brain Injury Be Considered a Chronic Disease?

People worry not so much about the research itself, but what the government or insurance companies do with it.

Read the original: Cleveland Clinic CEO Worries Comparative Effectiveness Could Stifle Innovation